CUSIP: 02290A102
Q2 2021 13F Holders as of 30 Jun 2021
-
Type / Class
-
Equity / SPONSORED ADS
-
Total 13F shares
-
13,929,686
-
Share change
-
+13,929,686
-
Total reported value
-
$266,216,000
-
Price per share
-
$19.60
-
Number of holders
-
20
-
Value change
-
+$266,215,999
-
Number of buys
-
20
Quarterly Holders Quick Answers
What is CUSIP 02290A102?
CUSIP 02290A102 identifies AMAM - AMBRX BIOPHARMA INC - SPONSORED ADS in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 02290A102:
Institutional Holders of AMBRX BIOPHARMA INC - SPONSORED ADS (AMAM) as of Q2 2021
As of 30 Jun 2021,
AMBRX BIOPHARMA INC - SPONSORED ADS (AMAM) was held by
20 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
13,929,686 shares.
The largest 10 holders included
FMR LLC, Cormorant Asset Management, LP, Fosun International Ltd, ADAGE CAPITAL PARTNERS GP, L.L.C., SUVRETTA CAPITAL MANAGEMENT, LLC, BlackRock Inc., Artal Group S.A., Octagon Capital Advisors LP, MILLENNIUM MANAGEMENT LLC, and Monashee Investment Management LLC.
This page lists
20
institutional shareholders reporting positions in this security
for the Q2 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.